MedPath

Investigating the effect of tranexamic acid on recovery time in patients undergoing total knee replacements

Phase 4
Conditions
Total Knee Arthroplasty
Peri-operative bleeding with Total Knee Arthroplasty
Surgery - Other surgery
Registration Number
ACTRN12621001327875
Lead Sponsor
Wesley Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Participants of either sex scheduled to undergo a primary, unilateral Total Knee Arthroplasty.
2. Available for follow up at 6 months post-surgery.
3. Willingness to provide written, informed consent.
4. Willingness to comply with the study.

Exclusion Criteria

1. Known allergy to TXA
2, Acquired disturbances to colour vision
3, Preoperative use of anticoagulants (within 5 days of surgery)
4. Fibrinolytic disorders requiring intraoperative fibrinolytics
5. Coagulopathy, history of arteriolar or venous thromboembolic disease
6. Pregnancy or breastfeeding
7. Haemoglobin <10g/dL

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath